Searched for
MANKIND PHARMA PROFIT
Bitcoin trades near $79,000 as Fed rate uncertainty, selling pressure weigh on crypto marketsBitcoin slipped near $79,000 as investors awaited the Federal Reserve’s policy decision. ETF outflows, macroeconomic uncertainty and sellin...- Worried about long-term returns? No equity mutual fund lost money on 5- and 7-year SIPsNo equity mutual fund delivered negative SIP returns over five- and seven-year periods, an ETMutualFunds analysis found. Quant Small Cap Fu...
- D-Street in gloomy mood, but Kotak sees 3 triggers for rebounds and adds 5 midcap stocks to portfolioDalal Street faces significant market challenges, leading Kotak Institutional Equities to spotlight selective stock value. With large-cap s...
- Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 croreMankind Pharma shares jumped nearly 8% after the company reported a 38% year-on-year rise in Q2 profit to Rs 716 crore. Revenue grew 17%, s...
- Mankind Pharma Q2 profit rises 38% to Rs 716 croreMankind Pharma has announced a profit increase of 37.7% to ₹716 crore during the September quarter. Revenue from operations rose to ₹4,337....
- Mankind Pharma shares key business developments from Q2 & H1 of FY27The company outperformed the market by 1.1 times in both chronic and acute therapies. Cardiac and anti-diabetes brands registered growth of...
- Stocks in news: Infosys, Kotak Mahindra Bank, YES Bank, Raymond, BPCL, Coforge and Senco GoldIndian equity markets have faced a decline for four consecutive sessions, with the Nifty falling significantly. Various factors, including ...
- Stocks in news: RIL, Wipro, Jio Financial, Tata Communications, YES Bank, PNBFrom a technical perspective, the 23,000–23,100 zone remains an immediate resistance level for the Nifty, according to Ponmudi R, CEO of En...
- Nifty rebound in sight after record 8-week losing streak: AnalystsNifty has dipped significantly, nearing a critical support range of 22,000 to 22,600, catching the attention of traders looking for a poten...
- Stocks in news: Bharti Airtel, Happiest Minds Technologies, PVR INOX, Milky Mist Dairy and Mankind PharmaIndian equity markets ended lower on August 31, responding to prevailing global economic dynamics. A modest decline in the Nifty50 index br...
- Elara initiates coverage on Alkem, Eris, IPCA and Mankind. Check ratings and targetsElara has initiated coverage on four pharmaceutical stocks, assigning Buy, Accumulate and Reduce ratings. Alkem Laboratories emerged as its...
- Mankind Pharma profit jumps 30% on chronic therapy demand in Q4Mankind Pharma announced a significant 30 percent profit increase for the fourth quarter. This growth was fueled by strong demand for chron...
- Stocks in news: ITC, Sun Pharma, IndusInd Bank, ABFRL, IndiGoMarkets saw volatility but closed higher. ITC, Sun Pharma, and IndusInd Bank are among the key stocks to watch. IndusInd Bank reported a ne...
- Mankind Pharma shares in focus after Q3 net profit drops 16% YoY to Rs 385 croreMankind Pharma's shares are in focus following a 16.5% YoY decline in Q3 net profit to Rs 385 crore, despite strong revenue growth of 24%. ...
- Mankind Pharma net profit drops 16% to Rs 385 crore in Q3FY25Mankind Pharma's Q3 FY25 net profit declined 16% YoY to ₹385 crore despite a 24% revenue increase to ₹3,230 crore. Domestic revenues rose 1...
- Mankind Pharma Q3 Results: Profit falls 16% to Rs 384 croreMankind Pharma on Thursday said its consolidated net profit declined 16.5 per cent to Rs 384 crore in the third quarter ended December 31, ...
- Mankind Pharma shares gain over 6% as profit jumps nearly 30% in Q2Mankind Pharma's shares surged by 6% after reporting a 29% rise in Q2 profits, reaching ₹658.88 crore. The company attributed this growth t...
- Mankind Pharma Q2 Results: Net profit rises 29% to Rs 659 crore, revenue up 13%Mankind Pharma witnessed a 29% surge in consolidated net profit, reaching Rs 658.88 crore in the second quarter, ending September 2024. Thi...
- Mankind Pharma shares plunge over 5% as I-T department raids Delhi officeShares of Mankind Pharma dropped 5.5% following news of India's income tax department conducting searches at its Delhi office. Its shares a...
- Mankind Pharma rallies 32% on day 1At Tuesday's closing price, Mankind Pharma was valued at a price-to-earnings ratio of 43 times its FY22 earnings. Mankind is now India's fi...
Load More
